Table 3 |
|||
|
Inclusion and Exclusion of the Bolinder Cohort in Karolinska Institute Studies |
|||
|
Year |
First Author [Ref] |
Bolinder In/Out |
Major Findings (RR) |
|
|
|||
|
1994 |
Bolinder [14] |
In |
All CV disease (1.4), All causes (1.4) |
|
2005 |
Odenbro [15] |
In |
Skin SCC (0.64) |
|
2007 |
Luo [8] |
Out |
Pancreatic cancer (2.0) |
|
2007 |
Odenbro [16] |
In |
Melanoma (0.65) |
|
2007 |
Fernberg [17] |
In |
Leukemia, MM (0.81* - 1.24*) |
|
2007 |
Hergens [18] |
Out |
MI (0.91*), fatal MI (1.28) |
|
2008 |
Zendehdel [19] |
In |
Esophageal SCC (3.5) Non cardia stomach cancer (1.4) |
|
2008 |
Hergens [20] |
Out |
Stroke (1.02*), fatal stroke (1.27*) |
|
2008 |
Hergens [21] |
Out |
Hypertension (1.23 - 1.39) |
|
2010 |
Carlens [22] |
Out |
Inflammatory diseases (0.9* - 1.1*) |
|
2011 |
Nordenvall [23] |
In |
Colon, rectal, anal cancer (1.05*, 1.08*, 0.61*) |
|
|
|||
|
Ref = Reference number RR = Relative Risk CV = Cardiovascular SCC = Squamous cell carcinoma MM = Multiple myeloma MI = Myocardial infarction * Not Statistically Significant. |
|||
|
Rodu Harm Reduction Journal 2011 8:19 doi:10.1186/1477-7517-8-19 |
|||
